Improving life for cancer patients through transformative drugs

Play

News

2018/09/10

Medivir appoints Dr. Linda Basse as Chief Medical Officer

Read more
2018/08/02

Investigator-initiated phase II clinical study of remetinostat started in patients with basal cell carcinoma

Read more
2018/07/27

MIV-711 osteoarthritis phase IIa extension study outcomes show continuing positive effect on joint structure

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.